As part of the recent resurgence of clinical psychedelic research, twelve volunteers with advanced cancer received treatment with psilocybin for anxiety in a study at the Harbor-UCLA Medical Center from 2005 until 2008. The quantitative data led monitors to conclude that the protocol was safe, but what did participants report about their subjective experiences? Several individuals from the study left us a legacy of stories of hope and healing with the intention of sharing their insights with others. This talk will feature first-person accounts of what it felt like and what it meant to be one of the brave participants in the first FDA-approved psilocybin trial since medicinal mushrooms were banned in 1971.
Alicia Danforth is a clinical psychedelic researcher. Since 2006, she has coordinated and co-facilitated treatment sessions for Dr. Charles Grob’s Harbor-UCLA cancer anxiety trial with psilocybin. She also oversees a nationwide Web-based recruitment effort for a similar trial currently underway at the Johns Hopkins School of Medicine. Inspired by seeing first-hand how psychedelic therapy can relieve suffering, she began a Ph.D. program in Clinical Psychology at the Institute of Transpersonal Psychology in Palo Alto. In 2008, she was a speaker on the ÒRising ResearchersÓ panel at the World Psychedelic Forum in Basel, Switzerland.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?